Chong Kun Dang and Pfizer will co-promote 2 glaucoma treatment products

Published: 2015-07-17 11:25:31

Updated: 2015-07-17 14:16:10

Chong Kun Dang is going to target the leading product market of a prostaglandin-type glaucoma treatment with Pfizer.

Chong Kun Dang(President Young-joo Kim) announced on the 16^th that it established the co-marketing contract of two glaucoma eye drops with Pfizer Korea at Grand Hyatt Seoul on the 15^th.

Under the contract, the company will conduct joint marketing of the Pfizer Korea’s glaucoma ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.